Schulz, F.; Jäger, P.; Tischer, J.; Fraccaroli, A.; Bug, G.; Hausmann, A.; Baermann, B.-N.; Tressin, P.; Hoelscher, A.; Kasprzak, A.;
et al. Smart Conditioning with Venetoclax-Enhanced Sequential FLAMSA + RIC in Patients with High-Risk Myeloid Malignancies. Cancers 2024, 16, 532.
https://doi.org/10.3390/cancers16030532
AMA Style
Schulz F, Jäger P, Tischer J, Fraccaroli A, Bug G, Hausmann A, Baermann B-N, Tressin P, Hoelscher A, Kasprzak A,
et al. Smart Conditioning with Venetoclax-Enhanced Sequential FLAMSA + RIC in Patients with High-Risk Myeloid Malignancies. Cancers. 2024; 16(3):532.
https://doi.org/10.3390/cancers16030532
Chicago/Turabian Style
Schulz, Felicitas, Paul Jäger, Johanna Tischer, Alessia Fraccaroli, Gesine Bug, Andreas Hausmann, Ben-Niklas Baermann, Patrick Tressin, Alexander Hoelscher, Annika Kasprzak,
and et al. 2024. "Smart Conditioning with Venetoclax-Enhanced Sequential FLAMSA + RIC in Patients with High-Risk Myeloid Malignancies" Cancers 16, no. 3: 532.
https://doi.org/10.3390/cancers16030532
APA Style
Schulz, F., Jäger, P., Tischer, J., Fraccaroli, A., Bug, G., Hausmann, A., Baermann, B. -N., Tressin, P., Hoelscher, A., Kasprzak, A., Nachtkamp, K., Schetelig, J., Hilgendorf, I., Germing, U., Dietrich, S., & Kobbe, G.
(2024). Smart Conditioning with Venetoclax-Enhanced Sequential FLAMSA + RIC in Patients with High-Risk Myeloid Malignancies. Cancers, 16(3), 532.
https://doi.org/10.3390/cancers16030532
